Trials / Suspended
SuspendedNCT01235273
Treatment of the lOw IGF-1 Syndrome aSsociated With Chronic Heart fAilure: A Randomized, Placebo-Controlled, Double-Blind Study.
Phase 2 Study of Growth Hormone Administration in Patients With Chronic Heart Failure and Low IGF-1 Levels
- Status
- Suspended
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Federico II University · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to determine whether treatment of the low IGF-1 syndrome in patients with CHF is able to modify some functional parameters, recognized as valid surrogate end-points of CHF progression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Growth Hormone | growth hormone administration |
| OTHER | Placebo | standard placebo |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2010-11-05
- Last updated
- 2014-02-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01235273. Inclusion in this directory is not an endorsement.